Business

Director- PDMR Dealing Announcement

Director- PDMR Dealing Announcement.

articleAdvanced Medical Solutions Group PlcMay 13, 20223/company/advanced-medical-solutions-group-plc/news/director-pdmr-dealing-announcement
Director- PDMR Dealing Announcement

About this update from Advanced Medical Solutions Group Plc

[{"type":"text","content":"\n \n \n \n \n \n \n \n  \n \n \n \n \n \n \n 13 May 2022\n \n \n \n \n \n \n \n  \n Advanced Medical Solutions Group plc\n \n \n (\"AMS\",\n the \"Company\"\n or the \"Group\")\n \n \n  \n \n \n \n  \n \n Director/PDMR Shareholding\n \n \n  \n \n \n Winsford, UK:\n Advanced Medical Solutions Group plc (AIM: AMS),\n the world-leading specialist in tissue-healing technologies\n , announces the following PDMR share transactions.\n \n \n  \n \n \n The Company\n was notified on 10 May 2022 that following his decision to participate in the\n Deferred Share Bonus (DSB), Chris Meredith, who is a Director and PDMR, undertook the following transactions:\n \n \n ·\n The exercise of \n 395,355 \n options from the \n Long-Term Incentive Plan (LTIP).\n \n \n ·\n The\n exercise of\n 34,608\n options from the existing\n Deferred Annual Bonus Plan (DAB).\n \n \n ·\n Elected to receive an additional 543 dividend shares which were earned during the holding period under the terms of the DAB.\n \n \n ·\n T\n he exercise of 23,415 Ordinary Shares of 5p from the existing DSB and the award of 56,785 shares under the DSB.\n \n \n ·\n The sale of\n 246,384 Ordinary Shares of 5p each on 10 May 2022\n at a share price of\n 271.5p\n per Ordinary Share by way of an off-market sale.\n The proceeds from the sale of the shares was used to purchase shares in the DSB and cover the tax payable on the above exercises.\n \n \n  \n \n \n The Trust which manages the Deferred Share Bonus Plan (\"DSB\") on behalf of the employees of AMS purchased ordinary shares of 5 pence each (\"Ordinary Shares\") between 10 and 12 May 2022, at an average price of 270.5p on behalf of Chris Meredith as part of the DSB and, under the terms of the DSB, these shares will be held in trust on his behalf.\n \n \n  \n \n \n As a result of these transactions\n Chris Meredith's\n beneficial interest in the Company increased and his overall holding is as follows:\n \n \n  \n \n \n \n \n \n \n PDMR\n \n \n \n \n No. of DSBs after exercise\n \n \n \n \n No. of DABs after exercise\n \n \n \n \n No. of LTIPs after exercise\n \n \n \n \n Resultant holding of Ordinary Shares\n \n \n \n \n % of issued share capital\n \n \n \n \n \n \n Chris Meredith\n \n \n \n \n 117,709\n \n \n \n \n 6,219\n \n \n \n \n 877,145\n \n \n \n \n 1,760,162\n \n \...

More updates from Advanced Medical Solutions Group Plc